Show Summary Details
Page of

Quality Improvement for Continuous Renal Replacement Therapies 

Quality Improvement for Continuous Renal Replacement Therapies
Chapter:
Quality Improvement for Continuous Renal Replacement Therapies
Author(s):

Ian Baldwin

and Rinaldo Bellomo

DOI:
10.1093/med/9780190225537.003.0031
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 29 May 2020

There are different clinical parameters that can reflect the successful use of CRRT and the achievement of relevant therapeutic goals. The major goals of CRRT include desired toxic solute clearance, acid – base homeostasis, electrolyte balance, appropriate fluid removal and balance and temperature control. These goals should ideally be achieved in a timely and cost effective manner. Establishing and maintaining a unit CRRT data base is useful to gauge success, compare unit performance to that of others and enable review or change over time to detect potentially useful trends in performance. This quality improvement process is useful in respect of the changing clinical context, personnel changes and training requirements, new devices and CRRT machines, access devices and technical variations in prescription for anticoagulation and fluid balance.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.